EUVIMEDEUVIMED entdecken
Open Access

Quantitative Susceptibility Mapping MRI in Deep-Brain Nuclei in First-Episode Psychosis

Marisleydis García Saborit, Alejandro Jara, Néstor Muñoz, Carlos Milovic, Angeles Tepper iD, Luz María Alliende, Carlos Mena, Bárbara Iruretagoyena, Juan Pablo Ramirez-Mahaluf, Camila Diaz, Ruben Nachar, Carmen Paz Castañeda und 4 weitere

Schizophrenia Bulletin · 07.09.2023 · 49 (5) · 1355-1363

DOI: 10.1093/schbul/sbad041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 08.04.2023. Verfasst von Marisleydis García Saborit und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical Engineering, Pontificia Universidad Catolica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Dopamine, Psychotic Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ANID, Fondecyt, Millennium Institute for Intelligent Healthcare Engineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psychosis is related to neurochemical changes in deep-brain nuclei, particularly suggesting dopamine dysfunctions. We used an magnetic resonance imaging-based technique called quantitative susceptibility mapping (QSM) to study these regions in psychosis. QSM quantifies magnetic susceptibility in the brain, which is associated with iron concentrations. Since iron is a cofactor in dopamine pathways and co-localizes with inhibitory neurons, differences in QSM could reflect changes in these processes.

Methods

We scanned 83 patients with first-episode psychosis and 64 healthy subjects. We reassessed 22 patients and 21 control subjects after 3 months. Mean susceptibility was measured in 6 deep-brain nuclei. Using linear mixed models, we analyzed the effect of case-control differences, region, age, gender, volume, framewise displacement (FD), treatment duration, dose, laterality, session, and psychotic symptoms on QSM.

Results

Patients showed a significant susceptibility reduction in the putamen and globus pallidus externa (GPe). Patients also showed a significant R2* reduction in GPe. Age, gender, FD, session, group, and region are significant predictor variables for QSM. Dose, treatment duration, and volume were not predictor variables of QSM.

Conclusions

Reduction in QSM and R2* suggests a decreased iron concentration in the GPe of patients. Susceptibility reduction in putamen cannot be associated with iron changes. Since changes observed in putamen and GPe were not associated with symptoms, dose, and treatment duration, we hypothesize that susceptibility may be a trait marker rather than a state marker, but this must be verified with long-term studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopaminePsychotic DisordersHumansBrainBrain MappingMagnetic Resonance ImagingIron

Stichwörter der Autor:innen

QSMR2* ratesdopaminemagnetic susceptibilityneuromelanin

Substanzen

DopamineIron

Autor:innen und Institutionen

  • Department of Electrical Engineering, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Biomedical Imaging Center, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Millennium Institute for Intelligent Healthcare Engineering, Santiago, Chile.
  • Department of Statistics, Mathematics Faculty, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • School of Electrical Engineering, Pontificia Universidad Catolica de Valparaiso, Valparaiso, Chile.
  • Department of Psychiatry, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.

ORCID-Profile: Angeles Tepper, Juan Undurraga, Nicolas Crossley

Förderung

  • ANID
  • Fondecyt
  • Millennium Institute for Intelligent Healthcare Engineering

Zitieren

APA

García Saborit, M., Jara, A., Muñoz, N., Milovic, C., Tepper, A., Alliende, L. M., Mena, C., Iruretagoyena, B., Ramirez-Mahaluf, J. P., Diaz, C., Nachar, R., Castañeda, C. P., González, A., Undurraga, J., Crossley, N., & Tejos, C. (2023). Quantitative Susceptibility Mapping MRI in Deep-Brain Nuclei in First-Episode Psychosis. Schizophrenia Bulletin, 49(5), 1355-1363. https://doi.org/10.1093/schbul/sbad041

Vancouver

García Saborit M, Jara A, Muñoz N, Milovic C, Tepper A, Alliende LM, et al. Quantitative Susceptibility Mapping MRI in Deep-Brain Nuclei in First-Episode Psychosis. Schizophrenia Bulletin. 2023;49(5):1355-1363. doi:10.1093/schbul/sbad041

BibTeX
@article{GarcaSaborit2023,
  author = {García Saborit, Marisleydis and Jara, Alejandro and Muñoz, Néstor and Milovic, Carlos and Tepper, Angeles and Alliende, Luz María and Mena, Carlos and Iruretagoyena, Bárbara and Ramirez-Mahaluf, Juan Pablo and Diaz, Camila and Nachar, Ruben and Castañeda, Carmen Paz and González, Alfonso and Undurraga, Juan and Crossley, Nicolas and Tejos, Cristian},
  title = {Quantitative Susceptibility Mapping MRI in Deep-Brain Nuclei in First-Episode Psychosis},
  journal = {Schizophrenia Bulletin},
  year = {2023},
  volume = {49},
  number = {5},
  pages = {1355--1363},
  doi = {10.1093/schbul/sbad041}
}
Kostenlos starten →